Latest news
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2 - fiercepharma.comfiercepharma.com · Fri, 07 Aug 2026 07:00:00 GMTLilly’s obesity pill Foundayo ‘disappointed’ in Q2, as injectables continue to boom - fiercepharma.comfiercepharma.com · Wed, 05 Aug 2026 15:42:35 GMTNovo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data - fiercebiotech.comfiercebiotech.com · Wed, 05 Aug 2026 12:00:00 GMTJ&J pays Sail $785M, charting course to possible in vivo CAR-T buyout - fiercebiotech.comfiercebiotech.com · Thu, 30 Jul 2026 07:00:00 GMT